Home > Kronos CDK9 Inhibitor

molecules of the month

<< Back to

Kronos Bio CDK9 inhibitor selective structure drug hunter molecules of the year KB-0742

Kronos CDK9 Inhibitor

Recent Publication

selective CDK9 inhibitor

oral Ph. I candidate for MYC-amp tumors

from microarray binding assay with lysate

KB-0742

Kronos Bio, Cambridge, MA

The Kronos CDK9 inhibitor, KB-0742, is an ultraselective inhibitor of cyclin-dependent kinase CDK9. The CDK family of kinases have been pursued as cancer drug targets for decades, but family…

this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.

LEARN MORE

Kronos CDK9 Inhibitor

this content is exclusive to Premium members

this content is exclusive to
Premium members